Good Sense Cold
Pricing Report NDC 0113-0308-62

Latest NADAC: $0.11967 per EA · Effective Dec 19, 2018 · Est. package price $2.87 (24 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Good Sense Cold Multi Symptom (NDC 0113-0308-62) is $0.11967 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 19, 2018.

As a provided by L. Perrigo Company, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 12 TABLET, FILM COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.11967
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 19, 2018
Billable Units
24 EA
Estimated Package Price
$2.87
Data Status
As of Dec 19, 2018
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0113-0308-62
Description
2 BLISTER PACK in 1 CARTON / 12 TABLET, FILM COATED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.08661 to $0.23585 per EA. Over this 5 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0866 - $0.2359
Market Volatility
172.31% Variance
Latest Trend
32.10%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Dec 19, 2018 $0.11967 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 21, 2018 $0.17625 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Oct 17, 2018 $0.20039 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 23, 2018 $0.11631 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 23, 2018 $0.11631 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Apr 18, 2018 $0.11964 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 21, 2018 $0.15297 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 21, 2018 $0.10280 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 20, 2017 $0.13497 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 20, 2017 $0.13497 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Nov 22, 2017 $0.10257 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Sep 20, 2017 $0.13045 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026